Literature DB >> 26686774

Immunosurveillance and immunotherapy of tumors by innate immune cells.

Alexandre Iannello1, Thornton W Thompson1, Michele Ardolino1, Assaf Marcus1, David H Raulet2.   

Abstract

Increasing evidence supports a role for innate immune effector cells in tumor surveillance. Natural killer (NK) cells and myeloid cells represent the two main subsets of innate immune cells possessing efficient but quite different tumor suppressive abilities. Here, we describe the germline-encoded NK cell receptors that play a role in suppressing tumor development and describe briefly the cellular pathways leading to the upregulation of their ligands in tumor cells. We also describe mechanisms underlying the elimination of tumor cells by macrophages and a recently characterized mechanism dedicated to sensing cytosolic DNA that is implicated in antitumor immune responses.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26686774      PMCID: PMC4715905          DOI: 10.1016/j.coi.2015.11.001

Source DB:  PubMed          Journal:  Curr Opin Immunol        ISSN: 0952-7915            Impact factor:   7.486


  73 in total

1.  Recognition and prevention of tumor metastasis by the NK receptor NKp46/NCR1.

Authors:  Ariella Glasner; Hormas Ghadially; Chamutal Gur; Noa Stanietsky; Pinchas Tsukerman; Jonatan Enk; Ofer Mandelboim
Journal:  J Immunol       Date:  2012-02-03       Impact factor: 5.422

2.  Pharmacological activation of p53 triggers anticancer innate immune response through induction of ULBP2.

Authors:  Hai Li; Tadepally Lakshmikanth; Cinzia Garofalo; Martin Enge; Clemens Spinnler; Andrea Anichini; Laszlo Szekely; Klas Kärre; Ennio Carbone; Galina Selivanova
Journal:  Cell Cycle       Date:  2011-10-01       Impact factor: 4.534

3.  Human NK cells are alerted to induction of p53 in cancer cells by upregulation of the NKG2D ligands ULBP1 and ULBP2.

Authors:  Sonja Textor; Nathalie Fiegler; Annette Arnold; Angel Porgador; Thomas G Hofmann; Adelheid Cerwenka
Journal:  Cancer Res       Date:  2011-07-15       Impact factor: 12.701

Review 4.  Programmed cell removal: a new obstacle in the road to developing cancer.

Authors:  Mark P Chao; Ravindra Majeti; Irving L Weissman
Journal:  Nat Rev Cancer       Date:  2011-12-08       Impact factor: 60.716

5.  The CD47-signal regulatory protein alpha (SIRPa) interaction is a therapeutic target for human solid tumors.

Authors:  Stephen B Willingham; Jens-Peter Volkmer; Andrew J Gentles; Debashis Sahoo; Piero Dalerba; Siddhartha S Mitra; Jian Wang; Humberto Contreras-Trujillo; Robin Martin; Justin D Cohen; Patricia Lovelace; Ferenc A Scheeren; Mark P Chao; Kipp Weiskopf; Chad Tang; Anne Kathrin Volkmer; Tejaswitha J Naik; Theresa A Storm; Adriane R Mosley; Badreddin Edris; Seraina M Schmid; Chris K Sun; Mei-Sze Chua; Oihana Murillo; Pradeep Rajendran; Adriel C Cha; Robert K Chin; Dongkyoon Kim; Maddalena Adorno; Tal Raveh; Diane Tseng; Siddhartha Jaiswal; Per Øyvind Enger; Gary K Steinberg; Gordon Li; Samuel K So; Ravindra Majeti; Griffith R Harsh; Matt van de Rijn; Nelson N H Teng; John B Sunwoo; Ash A Alizadeh; Michael F Clarke; Irving L Weissman
Journal:  Proc Natl Acad Sci U S A       Date:  2012-03-26       Impact factor: 11.205

6.  Retinoic acid early inducible genes define a ligand family for the activating NKG2D receptor in mice.

Authors:  A Cerwenka; A B Bakker; T McClanahan; J Wagner; J Wu; J H Phillips; L L Lanier
Journal:  Immunity       Date:  2000-06       Impact factor: 31.745

Review 7.  B7-H6/NKp30 interaction: a mechanism of alerting NK cells against tumors.

Authors:  Tomonori Kaifu; Bertrand Escalière; Louis N Gastinel; Eric Vivier; Myriam Baratin
Journal:  Cell Mol Life Sci       Date:  2011-08-30       Impact factor: 9.261

8.  NF-κB regulates MICA gene transcription in endothelial cell through a genetically inhibitable control site.

Authors:  Da Lin; Hayley Lavender; Elizabeth J Soilleux; Christopher A O'Callaghan
Journal:  J Biol Chem       Date:  2011-12-14       Impact factor: 5.157

9.  The antiviral factor APOBEC3G enhances the recognition of HIV-infected primary T cells by natural killer cells.

Authors:  Jason M Norman; Michael Mashiba; Lucy A McNamara; Adewunmi Onafuwa-Nuga; Estelle Chiari-Fort; Wenwen Shen; Kathleen L Collins
Journal:  Nat Immunol       Date:  2011-08-28       Impact factor: 25.606

10.  Expression of the RAE-1 family of stimulatory NK-cell ligands requires activation of the PI3K pathway during viral infection and transformation.

Authors:  Maria Tokuyama; Clarisse Lorin; Frederic Delebecque; Heiyoun Jung; David H Raulet; Laurent Coscoy
Journal:  PLoS Pathog       Date:  2011-09-22       Impact factor: 6.823

View more
  36 in total

1.  Contribution of NK cells to immunotherapy mediated by PD-1/PD-L1 blockade.

Authors:  Joy Hsu; Jonathan J Hodgins; Malvika Marathe; Chris J Nicolai; Marie-Claude Bourgeois-Daigneault; Troy N Trevino; Camillia S Azimi; Amit K Scheer; Haley E Randolph; Thornton W Thompson; Lily Zhang; Alexandre Iannello; Nikhita Mathur; Karen E Jardine; Georgia A Kirn; John C Bell; Michael W McBurney; David H Raulet; Michele Ardolino
Journal:  J Clin Invest       Date:  2018-09-10       Impact factor: 14.808

2.  Zinc-Induced Polymerization of Killer-Cell Ig-like Receptor into Filaments Promotes Its Inhibitory Function at Cytotoxic Immunological Synapses.

Authors:  Santosh Kumar; Sumati Rajagopalan; Pabak Sarkar; David W Dorward; Mary E Peterson; Hsien-Shun Liao; Christelle Guillermier; Matthew L Steinhauser; Steven S Vogel; Eric O Long
Journal:  Mol Cell       Date:  2016-04-07       Impact factor: 17.970

Review 3.  Role of metabolism during viral infections, and crosstalk with the innate immune system.

Authors:  Juan José González Plaza; Nataša Hulak; Galina Kausova; Zhaxybay Zhumadilov; Ainur Akilzhanova
Journal:  Intractable Rare Dis Res       Date:  2016-05

4.  Innate Immune System for Diagnostics and Therapy: Progress in Fundamental Knowledge and Clinical Application.

Authors:  Julia Kzhyshkowska; Peter Bugert
Journal:  Transfus Med Hemother       Date:  2016-03-31       Impact factor: 3.747

5.  The Atypical Receptor CCRL2 Is Essential for Lung Cancer Immune Surveillance.

Authors:  Annalisa Del Prete; Francesca Sozio; Tiziana Schioppa; Andrea Ponzetta; William Vermi; Stefano Calza; Mattia Bugatti; Valentina Salvi; Giovanni Bernardini; Federica Benvenuti; Annunciata Vecchi; Barbara Bottazzi; Alberto Mantovani; Silvano Sozzani
Journal:  Cancer Immunol Res       Date:  2019-09-04       Impact factor: 11.151

Review 6.  Tailoring Natural Killer cell immunotherapy to the tumour microenvironment.

Authors:  Alexander David Barrow; Marco Colonna
Journal:  Semin Immunol       Date:  2017-09-19       Impact factor: 11.130

Review 7.  Innate lymphoid cells: A potential link between microbiota and immune responses against cancer.

Authors:  Santosh K Panda; Marco Colonna
Journal:  Semin Immunol       Date:  2019-03-20       Impact factor: 11.130

Review 8.  Emerging roles of p53 and other tumour-suppressor genes in immune regulation.

Authors:  César Muñoz-Fontela; Anna Mandinova; Stuart A Aaronson; Sam W Lee
Journal:  Nat Rev Immunol       Date:  2016-09-26       Impact factor: 53.106

9.  EZH2 inhibition: a promising strategy to prevent cancer immune editing.

Authors:  Ning Kang; Mark Eccleston; Pier-Luc Clermont; Maryam Latarani; David Kingsley Male; Yuzhuo Wang; Francesco Crea
Journal:  Epigenomics       Date:  2020-09-17       Impact factor: 4.778

10.  NK cells prevent T cell lymphoma development in T cell receptor-transgenic mice.

Authors:  Sigrid Dubois; Lionel Feigenbaum; Thomas A Waldmann; Jürgen R Müller
Journal:  Cell Immunol       Date:  2020-02-27       Impact factor: 4.868

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.